Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 29 (RPL6P29)

Target: RPL6P29
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L6 pseudogene 29 (RPL6P29) is a processed pseudogene in the human genome. It is derived from the ribosomal protein L6 gene (RPL6), which encodes a component of the 60S subunit of ribosomes involved in protein synthesis. Like most pseudogenes, RPL6P29 does not produce a functional protein and is not involved in known biological pathways, disease processes, or therapeutic mechanisms. Pseudogenes such as RPL6P29 are common for ribosomal protein families, reflecting gene duplication or retrotransposition events during evolution, and are generally considered non-functional "genomic fossils" in the current human genome.

Other names: RPL6_17_1796RPL6P29

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 29 (RPL6P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 29 (RPL6P29).

Explore the full profile